Skip to main content
SpringerLink
Log in

The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis

  • Letter to the Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sekhar M, McVinnie K, Burroughs AK (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 162:730–747

    Article  CAS  PubMed  Google Scholar 

  2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissue, 4th ed. International Agency for Research on Cancer, Lyon

    Google Scholar 

  3. Langabeer SE, Andrikovics H, Asp J, et al (2015) Molecular diagnostics of myeloproliferative neoplasms. Eur J Haematol 95:270–279

  4. Dentali F, Squizzato A, Brivio L, et al (2009) JAK2 V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood 113:5617–5623

    Article  CAS  PubMed  Google Scholar 

  5. Pardanani A, Lasho T, Schwager S, et al (2007) JAK2 V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder. Leukemia 21:1828–1829

    Article  CAS  PubMed  Google Scholar 

  6. Toyama K, Karasawa M, Yamane A, et al (2009) Low allele burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome. Int J Hematol 89:517–522

    Article  CAS  PubMed  Google Scholar 

  7. Colaizzo D, Amitrano L, Guardascione MA, et al (2013) Outcome for patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Thromb Res 132:e99–e104

    Article  CAS  PubMed  Google Scholar 

  8. Haslam K, Molloy KM, Conneally E, Langabeer S (2014) Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms. Clin Chem Lab Med 52:e29–e31

    Article  CAS  PubMed  Google Scholar 

  9. Nielsen C, Bojesen SE, Nordestgaard BG, Kofoed KF, Birgens HS (2014) JAK2 V617F somatic mutation in the general population: myeloproliferative neoplasms development and progression rate. Haematologica 99:1448–1455

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Lippert E, Mansier O, Migeon M, et al (2014) Clinical and biological characterization of patients with low (0.1–2 %) JAK2 V617F allele burden at diagnosis. Haematologica 99:e98–e101

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Haematology, St. Vincent’s University Hospital, Dublin 4, Ireland

    Matthew Goodyer & Karen Murphy

  2. Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James’s Hospital, Dublin 8, Ireland

    Stephen E. Langabeer & Karl Haslam

Authors
  1. Matthew Goodyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen E. Langabeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl Haslam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karen Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen E. Langabeer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goodyer, M., Langabeer, S.E., Haslam, K. et al. The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis. Pathol. Oncol. Res. 22, 229–230 (2016). https://doi.org/10.1007/s12253-015-9994-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-015-9994-8

Keywords

Search

Navigation